Ticker Details
Zevra Therapeutics, Inc.
IPO Date:	April 13, 2015
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$704.89M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.22 | 2.87%
Avg Daily Range (30 D):	$0.34 | 2.89%
Avg Daily Range (90 D):	$0.38 | 3.22%

Institutional Daily Volume
Avg Daily Volume:	.67M
Avg Daily Volume (30 D):	1.11M
Avg Daily Volume (90 D):	1.32M

Trade Size
Avg Trade Size (Sh.):	88
Avg Trade Size (Sh.) (30 D):	72
Avg Trade Size (Sh.) (90 D):	81

Institutional Trades
Total Institutional Trades:	474
Avg Institutional Trade:	$1.37M
Avg Institutional Trade (30 D):	$1.48M
Avg Institutional Trade (90 D):	$1.68M
Avg Institutional Trade Volume:	.14M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.44M
Avg Closing Trade (30 D):	$1.67M
Avg Closing Trade (90 D):	$1.91M
Avg Closing Volume:	147.75K

News

Jul 24, 2026 @ 11:30 AM Zevra Therapeutics Provides Update on Regulatory S... Source: Na

Mar 18, 2026 @ 10:00 AM XOMA Royalty Reports 2025 Financial Results and Hi... Source: Na

Oct 6, 2025 @ 9:51 PM Zevra Therapeutics Announces Inducement Grants und... Source: Nichol Ochsner

Feb 27, 2025 @ 12:30 PM Zevra Therapeutics Enters Agreement to Sell its Ra... Source: Globe Newswire

Dec 6, 2024 @ 10:00 PM Zevra Therapeutics Announces Organizational Change... Source: N/A

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$.14	$.62	$.2
Diluted EPS	$.14	$.6	$.19
Revenue	$39.66M	$36.22M	$34.13M
Gross Profit
Net Income / Loss	$8.75M	$37.89M	$12.17M
Operating Income / Loss	$16.78M	$52.15M	$9.32M
Cost of Revenue
Net Cash Flow	$50.07M	$32.96M	$8.29M
PE Ratio

Splits
Dec 28, 2020	1:16